Abstract
Commercial serological assays for the presence of anti-glomerular basement membrane (GBM) antibodies are thought to be indicative of Goodpasture's syndrome. We report a case in which commercial tests inaccurately suggested that a patient with a pulmonary-renal syndrome had Goodpasture's disease. Additional laboratory testing using recombinant type IV collagen NC1 domain proteins showed that the autoantibodies in question were not directed against the Goodpasture antigen (the alpha3NC1 domain), but against the alpha2NC1 domain of type IV collagen. Our findings represent the first known case of human autoantibodies to the alpha2NC1 domain. Further investigation showed that this patient has decreased alpha3 and alpha5 chain expression in the GBM and defects in type IV collagen, resembling abnormalities in patients with Alport's syndrome.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Anti-Glomerular Basement Membrane Disease / diagnosis*
-
Antibody Specificity
-
Autoantibodies / immunology*
-
Autoantigens / genetics
-
Autoantigens / immunology*
-
Basement Membrane / immunology*
-
Blotting, Western
-
Collagen Type IV / chemistry
-
Collagen Type IV / immunology*
-
Diagnostic Errors*
-
Disease Progression
-
Enzyme-Linked Immunosorbent Assay
-
Follow-Up Studies
-
Humans
-
Kidney Glomerulus / immunology*
-
Kidney Glomerulus / pathology
-
Lung / pathology
-
Lung Diseases / diagnosis*
-
Lung Diseases / genetics
-
Lung Diseases / immunology
-
Male
-
Nephritis, Hereditary / diagnosis*
-
Nephritis, Hereditary / genetics
-
Nephritis, Hereditary / immunology
-
Protein Structure, Tertiary
-
Recombinant Fusion Proteins / immunology
-
Syndrome
Substances
-
Autoantibodies
-
Autoantigens
-
Collagen Type IV
-
Recombinant Fusion Proteins
-
type IV collagen alpha3 chain